How do I subscribe to ongoing alerts?

Subscribe to /feed/company/cliniques-universitaires-saint-luc-universit-catholique-de-louvain.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Cliniques universitaires Saint-Luc- Université Catholique de Louvain — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cliniques universitaires Saint-Luc- Université Catholique de Louvain pipeline: 6 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

6 marketed 0 filed 2 Phase 3 0 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Randomisation to mepolizumab	Randomisation to mepolizumab	marketed
patients with sunitinib or pazopanib	patients with sunitinib or pazopanib	marketed
exenatide (Byetta)	exenatide (Byetta)	marketed	GLP-1 receptor agonist	GLP-1R	Diabetes
Povidone-Iodine 10%	Povidone-Iodine 10%	marketed	Antiseptic [EPC]
Blood samples for DOAC measurement	Blood samples for DOAC measurement	marketed			Diagnostics / Laboratory Medicine
Randomisation to omalizumab	Randomisation to omalizumab	marketed	IgE antagonist monoclonal antibody	Immunoglobulin E (IgE)	Immunology / Allergy
Immunotherapeutic Agent	Immunotherapeutic Agent	phase 3			Immunology
O.M.T	O.M.T	phase 3	Antiarrhythmic	hERG channel	Cardiovascular

Therapeutic area mix

Other · 3
Cardiovascular · 1
Diabetes · 1
Diagnostics / Laboratory Medicine · 1
Immunology · 1
Immunology / Allergy · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 2 shared drug classes
Pfizer · 2 shared drug classes
Ain Shams University · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
AstraZeneca · 1 shared drug class
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders · 1 shared drug class
Amsterdam UMC, location VUmc · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Cliniques universitaires Saint-Luc- Université Catholique de Louvain:

Cite this brief

Drug Landscape (2026). Cliniques universitaires Saint-Luc- Université Catholique de Louvain — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cliniques-universitaires-saint-luc-universit-catholique-de-louvain. Accessed 2026-05-18.